Cite
HARVARD Citation
Iversen, L. et al. (2023). Secukinumab demonstrates superiority over narrow‐band ultraviolet B phototherapy in new‐onset moderate to severe plaque psoriasis patients: Week 52 results from the STEPIn study. Journal of the European Academy of Dermatology and Venereology. pp. 1004-1016. [Online].